|
Type 2 diabetes
Citations 391-400 of 449 total displayed.
|
Past content
(since Jan 2001):
|
- Basic Science Reports
Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus: Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase
- Ken Y. Lin, Akira Ito, Tomoko Asagami, Philip S. Tsao, Shanthi Adimoolam, Masumi Kimoto, Hideaki Tsuji, Gerald M. Reaven, and John P. Cooke
Circulation 2002;106:987-992; published online before print as doi:10.1161/01.CIR.0000027109.14149.67
[Abstract]
[Full text]
- Articles
Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation. Effects of Short- and Long-Term Simvastatin Treatment
- Antonio Ceriello, Claudio Taboga, Laura Tonutti, Lisa Quagliaro, Ludovica Piconi, Bruno Bais, Roberto Da Ros, and Enrico Motz
Circulation published August 19, 2002, doi:10.1161/01.CIR.0000027569.76671.A8
[Abstract]
- Editorials
Diabetic Nephropathy: Can Renoprotection Be Extrapolated to Cardiovascular Protection?
- Lionel H. Opie and Hans-Henrik Parving
Circulation 2002;106:643-645, doi:10.1161/01.CIR.0000028099.24188.C4
[Full text]
- Clinical Investigations and Reports
Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus: A Blood Pressure–Independent Effect
- Giancarlo Viberti, Nigel M. Wheeldon for the MicroAlbuminuria Reduction With VALsartan (MARVAL) Study Investigators
Circulation 2002;106:672-678; published online before print as doi:10.1161/01.CIR.0000024416.33113.0A
[Abstract]
[Full text]
- Clinical Investigations and Reports
Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus
- Steven M. Haffner, Andrew S. Greenberg, Wayde M. Weston, Hongzi Chen, Ken Williams, and Martin I. Freed
Circulation 2002;106:679-684; published online before print as doi:10.1161/01.CIR.0000025403.20953.23
[Abstract]
[Full text]
- Articles
Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus. Role of Asymmetric Dimethylarginine and Dimethylarginine Dimethylaminohydrolase
- Ken Y. Lin, Akira Ito, Tomoko Asagami, Philip S. Tsao, Shanthi Adimoolam, Masumi Kimoto, Hideaki Tsuji, Gerald M. Reaven, and John P. Cooke
Circulation published July 29, 2002, doi:10.1161/01.CIR.0000027109.14149.67
[Abstract]
- Brief Rapid Communications
Downregulation of Myocardial Myocyte Enhancer Factor 2C and Myocyte Enhancer Factor 2C–Regulated Gene Expression in Diabetic Patients With Nonischemic Heart Failure
- Peter Razeghi, Martin E. Young, Tonya C. Cockrill, O. Howard Frazier, and Heinrich Taegtmeyer
Circulation 2002;106:407-411; published online before print as doi:10.1161/01.CIR.0000026392.80723.DC
[Abstract]
[Full text]
- Clinical Investigations and Reports
Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells
- Massimo Federici, Rossella Menghini, Alessandro Mauriello, Marta Letizia Hribal, Francesca Ferrelli, Davide Lauro, Paolo Sbraccia, Luigi Giusto Spagnoli, Giorgio Sesti, and Renato Lauro
Circulation 2002;106:466-472; published online before print as doi:10.1161/01.CIR.0000023043.02648.51
[Abstract]
[Full text]
- Articles
Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus
- Steven M. Haffner, Andrew S. Greenberg, Wayde M. Weston, Hongzi Chen, Ken Williams, and Martin I. Freed
Circulation published July 15, 2002, doi:10.1161/01.CIR.0000025403.20953.23
[Abstract]
- Articles
Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus. A Blood Pressure--Independent Effect
- Giancarlo Viberti, Nigel M. Wheeldon for the MicroAlbuminuria Reduction With VALsartan (MARVAL) Study Investigators
Circulation published July 15, 2002, doi:10.1161/01.CIR.0000024416.33113.0A
[Abstract]
|
|
